PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30137220-2	2019	In this study, we first examined whether rosiglitazone, an agonist of the peroxisome proliferator-activated receptor-gamma (PPARgamma), protects the human trophoblast from oxidative injury by regulating key antioxidant proteins, catalase (CAT) and the superoxide dismutases (SOD1 and SOD2).	Rosiglitazone	41-54	superoxide dismutase 2	Homo sapiens	284-288	
30137220-5	2019	Treatment with rosiglitazone dose-dependently upregulated anti-oxidative CAT and SOD2, and rescued hypoxic injury in first trimester villous explants and JEG-3 cells, strongly suggesting the involvement of the PPARgamma in regulating their expressions.	Rosiglitazone	15-28	superoxide dismutase 2	Homo sapiens	81-85	
28964868-6	2017	The stimulation of mitochondrial function and anti-oxidative stress by rosiglitazone was associated with activation of the PGC1alpha pathway by up-regulation of mitochondrial (NRF-1 and Tfam) and oxidative defense (SOD1, SOD2 and Gpx1) genes.	Rosiglitazone	71-84	superoxide dismutase 2	Homo sapiens	221-225